Cardiovascular risk in Type 2 Diabetes

The risk of CVD mortality in type 2 diabetic patients is more than double compared with that in age-matched subjects. Stroke events and all manifestations of CHD, myocardial infarction (MI), sudden death, and angina pectoris is at least twofold more common in patients with type 2 diabetes than in non-diabetic individuals. A high proportion of patients with type 2 diabetes die after an acute MI within 1 year, and a considerable number of patients die outside the hospital. Relative risk for CHD events is higher in female patients with type 2 diabetes than in male patients with type 2 diabetes. The reason for the sex difference is largely unknown but could be at least in part explained by a heavier risk-factor burden and a greater effect of blood pressure and atherogenic dyslipidemia on the risk of CVD in diabetic women than in diabetic men.

The prognosis of patients with type 2 diabetes is highly dependent on the presence of CVD. We compared the 7-year incidence of fatal and nonfatal MI among 1,373 non-diabetic subjects with the incidence among 1,059 subjects with type 2 diabetes. Our study suggested that patients with type 2 diabetes without previous MI have as high a risk of MI as non-diabetic patients with previous MI. Thus, our results indicated that type 2 diabetes is a “coronary heart disease equivalent.” These results were recently replicated by an 18-year follow-up study of our original cohort and by a Danish study including 3.3 million subjects. One of the paradoxes in the studies of cardiovascular complications in type 2 diabetes is that at diagnosis individuals with type 2 diabetes already has substantially increased prevalence of CHD and stroke.

  • High Blood Pressure
  • Heart Disease
  • High Blood Glucose
  • Damage of Blood Vessels
  • Atherosclerosis and Hypertension
  • Shortness of Breath
  • Diabetic Neuropathy

Related Conference of Cardiovascular risk in Type 2 Diabetes

June 15-16, 2020

29th European Diabetes Congress

Barcelona, Spain
June 23-24, 2020

29th World Diabetes & Heart Congress

Tokyo, Japan
July 15-16, 2020

3rd Global Diabetes Summit

Helsinki, Finland
July 15-16, 2020

28th International Diabetes and Healthcare Conference

Helsinki, Finland
July 20-21, 2020

Annual Congress on Diabetes, Metabolism and Obesity

Manila, Philippines
August 17-18, 2020

16th World Congress on Endocrinology & Diabetes

Copenhagen, Denmark
August 24-25, 2020

Global Summit on Diabetes & Endocrinology

Kyoto, Japan
August 24-25, 2020

Annual Summit on Diabetes and Endocrinology

Barcelona, Spain
September 22-23, 2020

2nd Asia Pacific Endocrinology Congress

Singapore City, Singapore
September 28-29, 2020

4th Annual Congress on Diabetes, Obesity and Its Complications

Singapore City, Singapore
October 04-05, 2020

World Summit on Blood Glucose Monitoring

Beijing, China
October 07-08, 2020

International Summit on Diabetes

Barcelona, Spain
October 14-15, 2020

World Congress on Endocrinology & Diabetes

Rome, Italy
October 14-15, 2020

Global Congress on Endocrinology and Gynecology

Sydney, Australia
October 30-31, 2020

Annual Summit on Metabolomics

Vancouver, Canada
November 09-10, 2020

International Congress and Expo on Diabetic Care

Bangkok, Thailand
November 13-14, 2020

International Conference on Diabetes and Heart Diseases

Bangkok, Thailand
November 16-17, 2020

World Congress and Expo on Diabetes

Kyoto, Japan
November 16-17, 2020

2nd Asia Pacific Diabetes and Endocrinology Congress

Brisbane, Australia
November 18-19, 2020

Annual congress on Diabetes and Endocrinology Congress

Bangkok, Thailand
December 07-08, 2020

13th World Congress on Endocrinology and Metabolic Disorders

Auckland, Newzealand

Cardiovascular risk in Type 2 Diabetes Conference Speakers

Recommended Sessions

Related Journals

Are you interested in